BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Amnis Corporation Begins Shipment of New ImageStreamX Imaging Flow Cytometers


10/7/2009 7:06:38 AM

SEATTLE, Oct. 6 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the first commercial shipments of the new ImageStreamX imaging flow cytometers. The new instrument - the second generation of Amnis' patented ImageStream(R) technology - combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery, rich feature set, and functional insights of microscopy.

"The ImageStreamX is the result of focused technology development based on both a broad market research study and more than five years of very close work with our customer base," remarked William E. Ortyn, Amnis' co-founder and Chief Operating Officer. "If early market response is a good indicator of ultimate product success, then it appears this work was right on the mark," he added.

"Pre-sales of the ImageStreamX have greatly exceeded our expectations, particularly given the current economic climate," said David Basiji, Ph.D., Amnis' President and Chief Executive Officer. "These sales results are due to the dramatic performance increase combined with the greater affordability and modularity of the new ImageStreamX, which allows the instrument to fit into a much wider range of labs and budgets," explained Basiji. Mr. Ortyn added, "The ImageStreamX has many of the attributes necessary to perform in the clinical market place. Over the next several months we look forward to releasing a wide array of options and applications kits to further enhance product capabilities."

About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets. The initial ImageStream system, introduced in 2005, is in service in over 15 countries world-wide, and has an excellent track record of performance and reliability. Researchers have utilized ImageStream technology to produce over 80 groundbreaking publications and numerous conference posters and presentations.

www.amnis.com

SOURCE Amnis Corporation

CONTACT: David Basiji, President and Chief Executive Officer of Amnis
Corporation, +1-206-374-7000, or fax, +1-206-576-6895, info@amnis.com

Web site: http://www.amnis.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES